Skip to main content

Advertisement

Contact Hiroya Taniguchi

From: A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

Contact corresponding author